Postoperative Radiotherapy in Completely Resected Stage II and III Thymoma: How to Translate the Potential Survival Benefit in the Setting of the Future Adoption of the IASLC-ITMIG TNM-Based Staging System

J Thorac Oncol. 2017 Jan;12(1):e8-e9. doi: 10.1016/j.jtho.2016.09.128.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Forecasting
  • Humans
  • Lung Neoplasms*
  • Neoplasm Staging
  • Radiotherapy, Adjuvant
  • Thymoma*
  • Thymus Neoplasms